Objectives: : Botulinum neurotoxin (BoNT) reduces disabling muscle contraction in numerous disorders with muscle overactivity. While motor endplates are the primary site of action for BoNT, their location is unknown in most human muscles. This study localized the motor endplate bands (MEB) within human biceps brachii (BB) muscles in relation to external landmarks.
Methods: : Five human BB muscles were obtained from autopsy. Three muscles were processed for Sihler's stain, a nerve staining technique, and 2 were processed by whole-mount acetylcholinesterase stain.
Results: : The major MEB in BB is an inverted V-shaped band, 1 cm in width, located 7 cm superior to the olecranon laterally, 11 cm superior to the olecranon in the middle, and 8 cm above the olecranon medially. The ratio of MEB location to total olecranon-acromion length is 0.25 at the lateral edge, 0.39 in the midline, and 0.28 at the medial edge.
Conclusions: : This study localized MEB in human BB in reference to external landmarks. This data should improve the feasibility of endplate targeting when injecting BoNT in BB, which might enhance the clinical efficacy of these injections.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/CND.0b013e31815c13a7 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Stable Convergent Polyneuronal Innervation and Altered Synapse Elimination in Muscles from Patients with Blepharospasm Responding Poorly to Recurrent Botulinum Type-A Neurotoxin Injections.
Toxins (Basel)
November 2024
Institut des Neurosciences Paris-Saclay, UMR 9197, CNRS/Université Paris-Sud, 91198 Gif-sur-Yvette, Cedex, France.
Botulinum neurotoxin type-A (BoNT/A), which blocks quantal acetylcholine (ACh) release at the neuromuscular junction (NMJ), has demonstrated its efficacy in the symptomatic treatment of blepharospasm. In 3.89% of patients treated for blepharospasm at Tenon Hospital, BoNT/A was no longer effective in relieving the patient's symptoms, and a partial upper myectomy of the muscle was performed.
View Article and Find Full Text PDFOptimizing transport methods to preserve function of self-innervating muscle cells for laryngeal injection.
Laryngoscope Investig Otolaryngol
December 2024
Indiana University School of Medicine (IUSM) Indianapolis Indiana USA.
Objectives: Recently, our laboratory has discovered a self-innervating population of muscle cells, called motor endplate-expressing cells (MEEs). The cells innately release a wide variety of neurotrophic factors into the microenvironment promoting innervation when used as an injectable treatment. Unlike other stem cells, the therapeutic potential of MEEs is dependent on the cells' ability to maintain phenotypical cell surface proteins in particular motor endplates (MEPs).
View Article and Find Full Text PDFGiant miniature endplate potentials at vertebrate neuromuscular junctions: A review.
Eur J Neurosci
December 2024
Department of Pharmacological and Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, Texas, USA.
An unusually large amplitude spontaneous miniature endplate potentials (gMEPPs) occur naturally at low frequency at the vertebrate neuromuscular junction. Unlike the normal miniature endplate potentials (nMEPPs), these gMEPPs have long duration and long time to peak. More strikingly, gMEPPs seem to be independent of extracellular and intracellular Ca and have a greater temperature sensitivity than nMEPPs.
View Article and Find Full Text PDFMulti-Layered Implant Approach for Hemilaryngectomy Reconstruction in a Porcine Model.
Laryngoscope
February 2025
Department of Otolaryngology-Head and Neck Surgery, Indiana University School of Medicine, Indianapolis, Indiana, U.S.A.
Objective: Partial laryngectomies result in voice, swallowing, and airway impairment for thousands of patients in the United States each year. Treatment options for dynamic restoration of laryngeal function are limited. Thus, there is a need for new reconstructive approaches.
View Article and Find Full Text PDFExercise, disease state and sex influence the beneficial effects of Fn14-depletion on survival and muscle pathology in the SOD1 amyotrophic lateral sclerosis (ALS) mouse model.
Skelet Muscle
October 2024
Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, UK.
Background: Amyotrophic lateral sclerosis (ALS) is a devastating and incurable neurodegenerative disease. Accumulating evidence strongly suggests that intrinsic muscle defects exist and contribute to disease progression, including imbalances in whole-body metabolic homeostasis. We have previously reported that tumour necrosis factor (TNF)-like weak inducer of apoptosis (TWEAK) and fibroblast growth factor inducible 14 (Fn14) are significantly upregulated in skeletal muscle of the SOD1 ALS mouse model.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!